Health Canada is taking longer to assess generic drug applications, lengthening the wait until the cheaper pharmaceuticals can come to market, new data show.
The federal regulator’s delays mean that it takes more time before patients are able to access some medications, and also that both public and private insurers may spend more on drugs before the less expensive alternatives become available.
From The Globe and Mail via this RSS feed